Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

32.7K
Overview
32.7K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.2K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
Vaccinations01:51

Vaccinations

50.9K
Overview
50.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infections.

Cell reports. Medicine·2026
Same author

Contact Parallel Cascade Selection Molecular Dynamics (cPaCS-MD) for Accurate In Silico Prediction of Peptide Binding Free Energy.

Journal of chemical information and modeling·2025
Same author

Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses.

Cell reports·2025
Same author

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.

Vaccines·2025
Same author

Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4.

Journal of medicinal chemistry·2025
Same author

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort.

Vaccines·2025

Related Experiment Video

Updated: Dec 23, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.4K

Disordered epitopes as peptide vaccines.

Christopher A MacRaild1, Jeffrey Seow1, Sreedam C Das1

  • 1Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade Parkville 3052 Australia.

Peptide Science (Hoboken, N.J.)
|April 25, 2020
PubMed
Summary

Intrinsically disordered proteins, lacking a fixed structure, are promising targets for peptide vaccines. Designing these vaccines requires considering how antigen presentation influences antibody recognition for effective immune responses.

Keywords:
designintrinsically disordered antigenmalariamembrane interactionspeptide epitopestructure

More Related Videos

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.9K
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
13:58

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Published on: October 22, 2012

18.5K

Related Experiment Videos

Last Updated: Dec 23, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.4K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.9K
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
13:58

Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells

Published on: October 22, 2012

18.5K

Area of Science:

  • Vaccinology
  • Immunology
  • Protein Chemistry

Background:

  • Peptide-based vaccines are a long-standing goal in clinical research.
  • Intrinsically disordered proteins (IDPs) are crucial antigens in various human pathogens.
  • IDPs are frequently targeted by protective antibody responses, challenging previous assumptions.

Purpose of the Study:

  • To review the potential of intrinsically disordered protein antigens for peptide vaccine development.
  • To discuss the challenges and propose design principles for peptide vaccines targeting disordered antigens.

Main Methods:

  • Literature review focusing on disordered protein antigens and their epitopes.
  • Analysis of the conformational properties and antibody recognition of disordered antigens.
  • Discussion of vaccine design strategies considering antigen presentation and context.

Main Results:

  • Disordered protein antigens are suitable starting points for peptide vaccine development.
  • Disordered epitopes are predominantly linear, making them ideal for peptide vaccines.
  • Antibody recognition of disordered antigens is context-dependent, influencing vaccine design.

Conclusions:

  • Peptide vaccines targeting intrinsically disordered antigens offer a promising avenue for disease prevention.
  • Effective vaccine design must account for the dynamic conformational nature of disordered antigens.
  • Further research into context-dependent antigen presentation is crucial for successful vaccine development.